StockData
Jade Biosciences, Inc. logo

Jade Biosciences, Inc. (JBIO) stock

JBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30
$15.40+0.06 (+0.42%)

Close on Nov 17, 2026Market cap $979.40MP/E –Yield –

Jade Biosciences cash

Cash and short-term investments held at the end of each period.

Jade Biosciences's cash was $475.71M at Sep 30, 2026. For fiscal 2025 it was $336.16M, up 327.7% from the year before. The highest annual figure on record is $336.16M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$336.16M+327.7%
FY2024Dec 31, 2024$78.60M-35.8%
FY2023Dec 31, 2023$122.40M-5.3%
FY2022Dec 31, 2022$129.20M-22.8%
FY2021Dec 31, 2021$167.40M+3560.6%
FY2020Dec 31, 2020$4.57M+30.1%
FY2019Dec 31, 2019$3.51M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$475.71M+139.2%
Q2 FY2026Jun 30, 2026$461.21M+108.7%
Q1 FY2026Mar 31, 2026$311.30M+308.5%
Q4 FY2025Dec 31, 2025$336.16M+327.7%
Q3 FY2025Sep 30, 2025$198.91M+124.2%
Q2 FY2025Jun 30, 2025$220.94M+112.0%
Q1 FY2025Mar 31, 2025$76.20M-23.3%
Q4 FY2024Dec 31, 2024$78.60M-35.8%
Q3 FY2024Sep 30, 2024$88.70M-34.4%
Q2 FY2024Jun 30, 2024$104.20M-30.6%
Q1 FY2024Mar 31, 2024$99.30M-16.5%
Q4 FY2023Dec 31, 2023$122.40M-5.3%
Q3 FY2023Sep 30, 2023$135.20M-5.2%
Q2 FY2023Jun 30, 2023$150.10M-1.2%
Q1 FY2023Mar 31, 2023$118.90M-26.2%
Q4 FY2022Dec 31, 2022$129.20M-22.8%
Q3 FY2022Sep 30, 2022$142.60M-21.2%
Q2 FY2022Jun 30, 2022$152.00M+157.0%
Q1 FY2022Mar 31, 2022$161.10M+3422.9%
Q4 FY2021Dec 31, 2021$167.40M+2144.9%
Q3 FY2021Sep 30, 2021$180.88M+18508.8%
Q2 FY2021Jun 30, 2021$59.15M+1583.3%
Q4 FY2020Dec 31, 2020$4.57M–
Q3 FY2020Sep 30, 2020$7.46M–
Q2 FY2020Jun 30, 2020$972.00K–
Q4 FY2019Dec 31, 2019$3.51M–

More Jade Biosciences figures

See a number that looks wrong?